COMMUNIQUÉS West-GlobeNewswire

Larimar Therapeutics Announces Proposed Underwritten Public Offering

13/02/2024 - 22:18

BALA CYNWYD, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]

Voting Rights and Shares Capital of the Company

13/02/2024 - 22:15

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Feb. 13, 2024 (GLOBE NEWSWIRE [...]

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

13/02/2024 - 22:15

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 13 févr. 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]

Ipsen’s Onivyde® regimen, a potential new standard-of-care first-line therapy in metastatic pancreatic adenocarcinoma, approved by FDA

13/02/2024 - 22:08

Approval based on Phase III NAPOLI 3 clinical trial in which Onivyde ® regimen (NALIRIFOX) demonstrated statistically significant superiority and clinically meaningful improvements in overall survival and progression- [...]

Ipsen reçoit l’approbation de la FDA pour le schéma thérapeutique incluant Onivyde®, un potentiel nouveau traitement de référence en première ligne dans l'adénocarcinome du pancréas métastatique

13/02/2024 - 22:08

Approbation basée sur l'essai clinique de Phase III NAPOLI 3 dans lequel le schéma thérapeutique d'Onivyde ® (NALIRIFOX) a démontré une supériorité statistiquement significative ainsi que des améliorations cliniquement [...]

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

13/02/2024 - 22:05

Term loan agreement enables Company to accelerate development and enhance commercialization of ECO Synthesis™ manufacturing platform for RNAi therapeutics Financing bolsters cash position and provides additional [...]

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024

13/02/2024 - 22:05

ROCKVILLE, Md., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP

13/02/2024 - 22:05

Transplant of HIP-modified pancreatic islet cells provided lasting glucose control in a fully immunocompetent non-human primate (NHP), enabling the achievement of exogenous insulin independence without immunosuppression [...]

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

13/02/2024 - 22:05

BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and certain business [...]

Telomir Pharmaceuticals Announces Closing of Initial Public Offering

13/02/2024 - 22:05

BALTIMORE, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the development and commercialization of [...]

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update

13/02/2024 - 22:05

Phase 3 clinical study of RZ358 underway in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Benefit shown in individual patient cases with RZ358 for tumor-associated hyperinsulinism [...]

NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

13/02/2024 - 22:01

NAARDEN, The Netherlands and MIAMI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

13/02/2024 - 22:00

EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and [...]

Cytokinetics to Announce Fourth Quarter Results on February 27, 2024

13/02/2024 - 22:00

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 27, 2024 at 4:00 PM Eastern Time [...]

Psychedelic Science 2025 – the Fifth and Largest Psychedelic Conference in History – Announced for June 16-20 2025 in Denver, Colorado

13/02/2024 - 19:29

10+ stages, a city block of exhibitor space, dozens of workshops, and a whole universe of networking and social events planned SAN JOSE, Calif. , Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for [...]

Ontario Health Coalition: Families & Advocates Announce Legal Action as Ford Government Grants New Long-Term Care Licenses to Corporations with Hideous Records

13/02/2024 - 19:10

TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The daughter of a deceased long-term care resident and the Ontario Health Coalition are asking the court to require the Ford government live up to their own long-term care [...]

AirAnswers® Expands Its Home Health Check Program with a Bacteria Panel for Those Suffering from Environmentally Acquired Illnesses

13/02/2024 - 18:44

CHICAGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- AirAnswers, the leader in indoor environmental air sampling and testing, is proud to announce the introduction of its latest breakthrough in indoor air quality testing: the [...]

LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024

13/02/2024 - 16:37

BURLINGTON, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024, after the market [...]

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

13/02/2024 - 16:00

Company continues to make strides towards breakeven NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for the full year of 2023, its [...]